
Gilead signs lenacapavir access deal; Arvinas CEO to step down
Today, a brief rundown of news involving Gilead Sciences and Arvinas, as well as updates from Chugai Pharmaceutical, Recursion Pharmaceuticals and Dizal Pharma that you may have missed. Gilead Sciences on Wednesday said it would supply its HIV prevention …